Antiretroviral therapy and hypersensitivity
Hypersensitivity reactions have been observed with a number of different antiretroviral drugs, notably abacavir (Ziagen), the only nucleoside reverse transcriptase inhibitor known to cause the condition. Non-nucleoside reverse transcriptase inhibitors can also cause hypersensitivity reactions, although less frequently, while some protease inhibitors and the fusion inhibitor T-20 (enfuvirtide, Fuzeon) can produce similar symptoms, although they may not be caused by a true hypersensitivity.
latest aidsmap news
- High rate of death amongst patients with HIV diagnosed late
- CD4 cell count increases sustained up to five years in developing-world treatment programmes
- Raltegravir may have role in PEP if exposure involves drug-resistant HIV
- Excellent outcomes from five years of antiretroviral use in Botswana
- Study explores verbal and non-verbal communication in unprotected sex between men
- IL-2 provides quick ‘AIDS rescue’, but effect does not always last
- Once-a-day etravirine should work as first-line treatment
- Second-line combinations fail twice as often as first-line ones in the first year
- If you can't switch, better to stay on failing treatment than stop it, studies show
- Non-nucleoside resistance is efficiently transmitted within infection ‘clusters’
